多学科ICU查房中抗菌药物暂停对患者生存的影响:一项对照前后研究
该单中心对照前后研究纳入2016年10月至2020年3月连续入住东京某三级大学医学中心内科/外科ICU的16岁及以上患者,比较仅多学科查房阶段(阶段1,777例)与查房中加入抗菌药物暂停阶段(阶段2,796例)。主要结局为出院生存的亚分布风险比(SHR),采用多变量Fine-Gray模型分析,结果显示阶段2出院生存显著改善(SHR 1.13;95%CI 1.02-1.25),但ICU出院生存的SHR组间无显著差异。中断时间序列分析显示,实施抗菌药物暂停后每1000患者日静脉抗菌药物总使用天数下降(截距变化-178.26;95%CI -317.74至-38.78;斜率变化-7.00;95%CI -15.77至1.78)。作者结论认为,多学科查房中抗菌药物暂停与患者生存改善及使用天数减少相关。
要点
- 在ICU多学科查房中实施抗菌药物暂停(抗菌药物启动后第3、7、14天进行)与出院生存改善相关(SHR 1.13;95%CI 1.02-1.25)。
- 抗菌药物暂停未显著改善ICU出院生存(原文报告组间无显著差异)。
- 实施抗菌药物暂停后,每1000患者日静脉抗菌药物总使用天数下降:截距变化-178.26(95%CI -317.74至-38.78),斜率变化-7.00(95%CI -15.77至1.78)。
- 研究为单中心对照前后研究,阶段1(仅多学科查房)777例,阶段2(查房+抗菌药物暂停)796例。
适用人群与场景
- 2016年10月至2020年3月连续入住东京某三级大学医学中心内科/外科ICU的16岁及以上患者。
处置流程与药物剂量
- 由重症监护医师主导的ICU多学科查房于2016年10月引入;抗菌药物暂停于2018年6月随ICU查房实施。
- 抗菌药物暂停在抗菌药物启动后第3、7、14天进行。
研究设计与关键结果
- 研究设计:单中心对照前后研究,比较多学科查房阶段(阶段1)与多学科查房中加入抗菌药物暂停阶段(阶段2)。
- 样本量:阶段1共777例,阶段2共796例。
- 主要结局:采用多变量Fine-Gray模型计算出院生存的亚分布风险比(SHR),阶段2较阶段1出院生存显著改善(SHR 1.13;95%CI 1.02-1.25)。
- 次要结局:ICU出院生存的SHR组间无显著差异。
- 次要结局:中断时间序列分析显示,实施抗菌药物暂停后每1000患者日静脉抗菌药物总使用天数下降(截距变化-178.26;95%CI -317.74至-38.78;斜率变化-7.00;95%CI -15.77至1.78)。
证据类型、等级与局限
- 证据类型:单中心对照前后研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,多学科查房中实施抗菌药物暂停与患者生存改善及静脉抗菌药物使用天数减少相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: The antimicrobial stewardship program (ASP) is an important quality improvement initiative that is recommended in the ICU. However, the shortage of infectious disease physicians in Japan has led to the need for simpler methods for implementing ASPs. We investigated whether antibiotic time-outs (ATOs) during multidisciplinary rounds as part of an ASP can improve patient survival and reduce the number of days of therapy (DOT) with antibiotics.
DESIGN: Single-center controlled before-and-after study.
SETTING: Medical/surgical ICU in a tertiary university medical center in Tokyo, Japan.
PATIENTS: All patients 16 years old or older admitted consecutively in the ICU between October 2016 and March 2020.
INTERVENTIONS: An intensivist-driven ICU multidisciplinary round was introduced in October 2016, and ATOs with ICU rounds were implemented in June 2018. ATOs were conducted 3, 7, and 14 days after initiation of antibiotics.
MEASUREMENTS AND MAIN RESULTS: The primary outcome was the subdistribution hazard ratio (SHR) of survival to hospital discharge compared between multidisciplinary rounds (phase 1) and ATO during multidisciplinary rounds (phase 2) using the multivariable Fine-Gray model. The secondary outcomes were the SHR of survival to ICU discharge and the trends in the DOT with IV antibiotics per 1,000 patient-days between October 2016 and March 2020 by using interrupted time-series analysis. The number of patients in phases 1 and 2 was 777 and 796, respectively. The group that underwent ATO during multidisciplinary rounds showed a significant increase in the survival to hospital discharge in comparison with the multidisciplinary round-only group (SHR, 1.13; 95% CI, 1.02-1.25); however, the SHR of survival to ICU discharge showed no significant intergroup difference. The DOT with total IV antibiotics decreased after ATO implementation (change in intercept, -178.26; 95% CI, -317.74 to -38.78; change in slope, -7.00; 95% CI, -15.77 to 1.78).
CONCLUSIONS: ATOs during multidisciplinary rounds are associated with improved patient survival and reduced DOT.
参考来源
- Mishima Y, Nawa N, Asada M, et al. Impact of Antibiotic Time-Outs in Multidisciplinary ICU Rounds for Antimicrobial Stewardship Program on Patient Survival: A Controlled Before-and-After Study. Crit Care Explor. 2023. PMID: 36699244. doi:10.1097/CCE.0000000000000837
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。